Related Experiment Video

Updated: May 25, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

3rd Pavia international symposium on advanced kidney cancer

Camillo Porta1, Sergio Bracarda

  • 1I.R.C.C.S. San Matteo University Hospital Foundation, Medical Oncology , 27100 Pavia , Italy.

Expert Opinion on Pharmacotherapy
|January 24, 2012
PubMed

Insights

Novel targeted agents have transformed kidney cancer treatment, yet optimal strategies and patient management remain areas for research. This report summarizes key advances discussed at the 3rd Pavia International Symposium on Advanced Kidney Cancer.

Area of Science:

  • Oncology
  • Nephrology
  • Pharmacology

Background:

  • The natural history of kidney cancer has been significantly altered by recent advancements in targeted therapies.
  • Despite progress, critical questions persist regarding optimal first-line treatments, treatment sequencing, and managing specific patient populations like the elderly or those with comorbidities.

Framework:

  • The 3rd Pavia International Symposium on Advanced Kidney Cancer convened experts to discuss recent breakthroughs.
  • The symposium aimed to foster dialogue on kidney cancer pathogenesis and therapeutic strategies.

Implementation:

  • Key advances across various disciplines relevant to advanced kidney cancer were presented.
  • Discussions focused on the practical application of new findings in clinical settings.

Implications:

  • These advances are poised to reshape the clinical perspective and management of patients with advanced kidney cancer.
  • Continued research and discussion are vital to address remaining challenges in kidney cancer care.

More Related Videos

Whole-Kidney Three-Dimensional Staining with CUBIC04:31

Whole-Kidney Three-Dimensional Staining with CUBIC

Published on: July 18, 2022

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Imaging Studies I: Kidney, Ureter, and Bladder Studies01:28

Imaging Studies I: Kidney, Ureter, and Bladder Studies

Kidney, Ureter, and Bladder (KUB) StudiesKidney, Ureter, and Bladder (KUB) studies are standard diagnostic imaging procedures used to assess the anatomy of the urinary system. They are commonly utilized for patients experiencing abdominal pain or urinary symptoms. By using a simple X-ray of the abdomen, KUB studies can reveal structural and pathological abnormalities within the kidneys, ureters, and bladder. These studies are particularly valuable in diagnosing kidney stones, urinary...